Phosphine stabilized compounds [Cu(I)(S2CNEt2)PR3]2 (1–3) (R = OMe, Me and Et, respectively) and [Cu(I)(S2COEt)PR3]2 (4, 5), (R = OMe, and Me, respectively) have been prepared and characterised. The structures of compounds (1–3) were determined by X-ray single crystallography. The structures of all three compounds are based on centro-symmetric dimers which crystallise in the monoclinic space group P21/n with two [Cu(I)(S2CNEt2)PR3]2 molecules per unit cell. The thermal decomposition of selected complexes was investigated by thermogravimetric, differential scanning calorimetry and gas chromatography with mass spectroscopy to understand the possible decomposition pathways.
No takes yet. Share an insight, caveat, or question.
Afzaal et al. (2011) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: